SCHEMBL26458463

SCHEMBL26458463

COc1cc(C)ncc1N1CCN(C(=O)c2ccc(Oc3ccccc3)cn2)[C@@H]([C@H](C)O)C1

nearest known ligand 0.84

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRPC6 Q9Y210 19/20 0.84
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26458433 1.00 TRPC6 (0.84) TRPC6PDGFRBPDGFRA
SCHEMBL21045768 0.91 TRPC6 (1.00) TRPC6
SCHEMBL30387614 0.91 TRPC6 (1.00) TRPC6
SCHEMBL21045804 0.91 TRPC6 (1.00) TRPC6
SCHEMBL30387453 0.91 TRPC6 (1.00) TRPC6
SCHEMBL23047371 0.91 TRPC6 (1.00) TRPC6
SCHEMBL21045765 0.91 TRPC6 (1.00) TRPC6
SCHEMBL26458499 0.77 TRPC6 (0.86) TRPC6
SCHEMBL26458492 0.77 TRPC6 (0.86) TRPC6
SCHEMBL21085646 0.76 TRPC6 (1.00) TRPC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137816-A1 ADMINISTRATION OF CALCIUM CHANNEL TRPC6 INHIBITORS USING BALLOONS, STENTS OR OTHER MEDICAL DEVICES DEUTSCHES HERZZENTRUM MUENCHEN DES FREISTAATES BAYERN (DE) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137816-A1 ADMINISTRATION OF CALCIUM CHANNEL TRPC6 INHIBITORS USING BALLOONS, STENTS OR OTHER MEDICAL DEVICES TRPC6, TRPC1, ORAI1 TRPC6 1/4885PDGFRB 261/4885PDGFRA 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.